Drug-Eluting Stents and Late Adverse Clinical Outcomes
Author:
- Sotirios TsimikasSTSotirios Tsimikas
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Two-Year Outcomes After Sirolimus-Eluting Stent ImplantationJACC, 2006
- Sirolimus-Eluting Stents Remain Superior to Bare-Metal Stents at Two YearsJACC, 2006
- Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting StentsJACC, 2006
- Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen LossCirculation, 2006
- Allergic Reactions After the Implantation of Drug-Eluting StentsJACC, 2006
- Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III TrialJACC, 2006
- Sirolimus-Eluting Stents Associated With Paradoxic Coronary VasoconstrictionJACC, 2005
- Endothelial Progenitor Cell Capture by Stents Coated With Antibody Against CD34JACC, 2005
- Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary modelCardiovascular Research, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004